Nuvectis PharmaNVCT
13F holders, Q4 2025 (December 31)48holders −5
3new positions
8sold out
$7.56avg. 13F price*
At the end of Q4 2025, 48 institutions reported holding Nuvectis Pharma Inc. (NVCT) in their 13F filings, down 5 from Q3 2025. 3 opened new positions and 8 sold out. The largest holders were Vanguard Group Inc. ($6.4M), BlackRock, Inc. ($5.9M) and Iridian Asset Management LLC ($4.4M).
- Company
- Nuvectis Pharma Inc.
- CUSIP
- 67080T108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $135K |
| Exits | 8 | $822K |
All 13F filers, Q3 2025 → Q4 2025: 751,886 shares bought and 207,996 shares sold, net +543,890 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Vanguard Group Inc. | 0.00% | Add +21.0% | 845,502 | $6.4M |
| BlackRock, Inc. | 0.00% | Add +14.2% | 782,805 | $5.9M |
| Iridian Asset Management LLC | 1.63% | Add +44.5% | 586,320 | $4.4M |
| Baldwin Wealth Partners LLC | 0.19% | Add +11.2% | 389,625 | $2.9M |
| Occam Crest Management LP | 2.06% | Add +31.0% | 380,000 | $2.9M |
| Geode Capital Management, LLC | 0.00% | Add +11.8% | 364,024 | $2.7M |
| State Street Corp. | 0.00% | Add +13.1% | 154,666 | $1.2M |
| Susquehanna International Group, LLP | 0.00% | Add +47.6% | 134,154 | $1.0M |
| Northern Trust Corp. | 0.00% | Add +9.2% | 116,405 | $879K |
| Oppenheimer & Co. Inc. | 0.01% | Add +6.5% | 73,566 | $555K |
| Forbes J M & Co. LLP | 0.04% | No change | 59,000 | $445K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +15.9% | 44,022 | $332K |
| Bank of New York Mellon Corp | 0.00% | Add +12.7% | 31,635 | $239K |
| Morgan Stanley | 0.00% | Add +51.3% | 28,011 | $211K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -41.3% | 26,503 | $200K |
| Barclays PLC | 0.00% | Add +31.3% | 24,185 | $183K |
| Austin Wealth Management, LLC | 0.03% | No change | 20,125 | $178K |
| Wells Fargo & Company | 0.00% | Add +114.1% | 16,929 | $128K |
| Nuveen, LLC | 0.00% | No change | 16,749 | $126K |
| Edmond DE Rothschild Holding S.A. | 0.00% | No change | 15,170 | $115K |
| CIBC Private Wealth Group LLC | 0.00% | New | 14,574 | $110K |
| Avalon Trust Co | 0.01% | Add +40.0% | 14,000 | $106K |
| Bank of America Corp. | 0.00% | Add +67.5% | 13,470 | $102K |
| Nations Financial Group Inc, /Ia/ | 0.01% | No change | 13,000 | $98K |
| Deutsche Bank AG | 0.00% | Add +3671.4% | 12,672 | $96K |
| Rhumbline Advisers | 0.00% | Reduce -25.6% | 8,433 | $64K |
| UBS Group AG | 0.00% | Reduce -67.1% | 8,375 | $63K |
| FMR LLC | 0.00% | Add +10661.2% | 7,210 | $54K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +19.6% | 7,198 | $54K |
| JPMorgan Chase & Co. | 0.00% | Add +20.0% | 6,382 | $48K |
| New York State Common Retirement Fund | 0.00% | No change | 5,000 | $38K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | No change | 3,785 | $29K |
| BNP Paribas Financial Markets | 0.00% | Add +26.6% | 3,541 | $27K |
| Lanark Financial, Inc. | 0.00% | New | 3,000 | $23K |
| Legal & General Group Plc | 0.00% | No change | 1,434 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -63.2% | 1,418 | $11K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 1,314 | $10K |
| Russell Investments Group, Ltd. | 0.00% | No change | 1,066 | $8K |
| California State Teachers Retirement System | 0.00% | Add +18.5% | 953 | $7K |
| Royal Bank of Canada | 0.00% | Reduce -97.0% | 922 | $7K |
| Amalgamated Bank | 0.00% | Add +10.4% | 486 | $4K |
| Citigroup Inc. | 0.00% | Reduce -29.3% | 386 | $3K |
| Spire Wealth Management | 0.00% | New | 300 | $2K |
| GAMMA Investing LLC | 0.00% | Add +94.3% | 171 | $1K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 100 | $755 |
| Sterling Capital Management LLC | 0.00% | Add +171.0% | 84 | $634 |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -58.2% | 23 | $174 |
| Cwm, LLC | 0.00% | Reduce -5.7% | 33 | $0 |
"% of holder's portfolio" is NVCT's weight in each manager's 13F, not the share of Nuvectis Pharma Inc. the manager owns.